Acelyrin, Inc.
SLRN
$2.69
-$0.06-2.18%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -25.94% | -32.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -52.77% | 12.38% | |||
| Operating Income | 52.77% | -12.38% | |||
| Income Before Tax | 43.33% | -144.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 43.33% | -144.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 43.33% | -144.97% | |||
| EBIT | 52.77% | -12.38% | |||
| EBITDA | 52.82% | -12.32% | |||
| EPS Basic | 43.72% | -141.88% | |||
| Normalized Basic EPS | 56.24% | -20.27% | |||
| EPS Diluted | 43.72% | -141.88% | |||
| Normalized Diluted EPS | 56.24% | -20.27% | |||
| Average Basic Shares Outstanding | 0.68% | 1.27% | |||
| Average Diluted Shares Outstanding | 0.68% | 1.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
